Skip to content

Effectiveness of Ayurvedic Kadha in Raktatisara (ulcerative colitis)

To Evaluate Effectiveness of Dadima Vatsak Kwatha in Management of Raktatisara(ulcerative colitis): A Pilot study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/030913
Enrollment
10
Registered
2021-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K519- Ulcerative colitis, unspecified

Interventions

Intervention1: Dadima Vatsak Kwatha: Dadima Vatsak Kwath will be provided in form of powdered raw material for the purpose of making fresh decoction. Decoction thus formed will be given in dose of 50m

Sponsors

Chaudhary Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Uncomplicated cases of ulcerative colitis of moderate to severe category in severity as per Modified True Love Witts severity index of diagnosis of ulcerative colitis and exhibiting symptoms of raktatisar i.e. excessive passing of rakta mishrita mala for more than three times per day Documented diagnosis(endoscopic, surgical or x-ray, patient must have one of these reports) of ulcerative colitis(UC) Patients who are ready to give consent for trial with firm residential address and contact numbers.

Exclusion criteria

Exclusion criteria: Any serious life threatening disease Concomitant Ayurvedic or any other treatment for any illness Patients below 21 years and above 50 years Pregnant and lactating mothers Any episode of MI in last 3months Hospitalization in last 3 months due to any heart problem and poorly controlled hypertension. Positive stool culture for enteric pathogens(salmonella, shigella, and campylobacter), positive stool ova and parasite exam. Any major psychiatric illness Malabsorption syndrome Tuberculosis, lactose intolerance, IBS, Crohnâ??s disease, coeliac disease, gluten intolerance, CA colon and rectum, diabetes mellitus, malignancy and any other disorder

Design outcomes

Primary

MeasureTime frame
Reduction in Modified Truelove Witts Severity Index scoreTimepoint: Day1, Day7, Day14,Day21, Day28

Secondary

MeasureTime frame
Attainment of status of Dhatu Samayata and VikaropsamaTimepoint: Day1, Day28;CBC assessmentTimepoint: Day1, Day28;Improvement in graded symptom severity of raktatisaraTimepoint: Day1, Day7, Day14,Day21, Day28;Improvement in inflammatory markers of ESR, CRPTimepoint: Day1, Day28;Stool examinationTimepoint: Day1, Day28

Countries

India

Contacts

Public ContactDr Yogesh Kumar Pandey

Chaudhary Brahm Prakash Ayurved Charak Sansthan

naraniadevendrakumar@gmail.com8058293991

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026